packageSitravatinib

sitravatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sitravatinib is an investigational protein kinase inhibitor being studied as a cancer treatment. It is not yet approved; it remains in clinical development and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27275860 and the WHO ATC classification; not checked by a person.

name:sitravatinib
ATC codes:L01EX26
DrugBank:DB15036
PubChem CID:25212148
Wikidata:Q27275860
formula:C33H29F2N5O4S
molar mass:629.682 g/mol (PubChem CID 25212148)
logP:5.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown